Glycated serum protein is independently associated with progressive infarction in patients with acute ischemic stroke

Keji Zou,Caixia Wei,Qin Huang,Zubing Xu,Xiaocheng Mao,Hudie Zhang,Chenying Zeng,Lanjiao Zhang,Jing Lin,Yuling Yi,Jinchong Zhang
DOI: https://doi.org/10.1177/03000605241245299
2024-04-14
Journal of International Medical Research
Abstract:Journal of International Medical Research, Volume 52, Issue 4, April 2024. ObjectiveThis study investigated the relationship between glycated serum protein (GSP) and progressive infarction (PI).MethodsFrom April 2017 to December 2020, we recruited 477 patients within 48 hours after the onset of acute ischemic stroke into this case–control study. Demographic characteristics, clinical information, and laboratory and neuroimaging data were recorded after admission.ResultsPI occurred in 144 (30.8%) patients. Patients with PI had higher initial National Institute of Health Stroke Scale (NIHSS) scores, higher discharge NIHSS scores, higher modified Rankin scale scores at 3 months after onset, higher GSP levels, lower prothrombin times, and lower creatinine levels than patients without PI. The likelihood of PI increased with increases in the GSP quartile. Multiple regression analysis revealed that high GSP levels (>2.14 mmol/L) were independently associated with PI. Subgroup analyses identified high GSP levels as an independent predictor of PI in patients with large artery atherosclerosis (third quartile: odds ratio [OR] = 3.793; 95% confidence interval [CI] = 1.555–9.250; fourth quartile: OR = 2.675; 95% CI = 1.056–6.776) and anterior circulation small vessel occlusion (fourth quartile: OR = 13.859; 95% CI = 2.024–94.885).ConclusionsGSP might be an independent predictor for PI in certain patients with acute ischemic stroke.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?